Jeremy Whitaker
Analyst · Krishna Shankar with Roth Capital
Thank you, Kurt. By now, many of you have seen our Q4 and fiscal 2012 news release, which is available on the Investor Relations section of our website at www.lantronix.com, and provides income statement and balance sheet information on our full fiscal year and quarterly results. I'd now like to take a few minutes to go over the highlights of our results from the fourth quarter of fiscal 2012.
Net revenue for the 3 months ended June 30, 2012, was $11.6 million, a decrease of 4% compared to $12.0 million for the 3 months ended June 30, 2011. And sequentially, a decrease of 4% compared to $12.1 million for the 3 months ended March 31, 2012. The year-over-year change was due to decreases in our device enablement and device management product lines, which were partially offset by an increase in our xPrintServer, Spider and PremierWave EN product families. The sequential decrease in net revenue was primarily due to lower sales in our EMEA region that we believe are the result of economic uncertainty and instability in the eurozone. A decrease in sales of SLC console servers, which tends to vary based upon the timing of data center build-outs and projects and the slight decrease in sales resulting from supply constraints. We've made some good progress towards remediating this issue; however, we may continue to see some constraints during the first fiscal quarter of 2013.
While our business has traditionally been lumpy, the continuing economic uncertainty combined with a typical summer slowdown in eurozone has further reduced our visibility in the Q1. Gross profit as a percentage of net revenue for the 3 months ended June 30, 2012, was 50.7% compared to 46.1% for the 3 months ended June 30, 2011, and 48.8% for the 3 months ended March 31, 2012. This represents the fourth sequential quarter of margin improvement. While we may experience downward pressure on our gross margins due to product mix as new, lower-margin products start to make up a larger portion of our total sales, we expect our gross margin to remain within the company's target model range during fiscal 2013.
Selling, general and administrative expenses were $4.2 million for the 3 months ended June 30, 2012, a decrease of $3.1 million or 43% compared to $7.3 million for the 3 months ended June 30, 2011, and up sequentially by $105,000 or 3% from $4.1 million for the 3 months ended March 31, 2012. The year-over-year decrease in SG&A expenses were primarily due to costs of $2.5 million associated with an independent investigation and severance for former named executive officers during the fourth quarter of fiscal 2011. There were no similar costs during the fourth fiscal quarter of 2012. In large part, the remaining balance of the decrease in SG&A expenses of approximately $600,000 can be attributed to the cost containment activities that management began to implement during the second fiscal quarter of 2012. During the first fiscal quarter of 2013, we may experience a slight increase in SG&A expenses as a result of professional fees related to the timing of our annual audit and proxy statement.
Research and development expenses were $1.8 million for the 3 months ended June 30, 2012, and remained essentially flat from the same quarter in fiscal 2011 and the third quarter of fiscal 2012. During fiscal 2013, we expect our R&D expenses may trend upward as we continue to execute on new product development.
GAAP net loss was $178,000 for the 3 months ended June 30, 2012 or $0.01 per share compared to a GAAP net loss of $3.6 million or $0.34 per share for the 3 months ended June 30, 2011, and sequentially, a GAAP net loss of $41,000 or $0.00 per share for the 3 months ended March 31, 2012.
Non-GAAP net income for the 3 months ended June 30, 2012, was $351,000 or $0.03 per share, compared to non-GAAP net loss of $433,000 or $0.04 per share for the 3 months ended June 30, 2011, and sequentially, non-GAAP net income of $471,000 or $0.04 per share for the 3 months ended March 31, 2011.
We expect to maintain a quarterly non-GAAP breakeven point at or below $11 million in quarterly net revenue. This assumes a 50% gross margin and takes into consideration our variable costs such as variable compensation. Now, turning to the balance sheet. Cash and cash equivalents as of June 30, 2012, were $11.4 million, compared to $5.8 million as of June 30, 2011 and $1.8 million as of March 31, 2012. The increase in cash was due to the sale of our common stock in April and May 2012, which generated net proceeds of approximately $9.5 million. During fiscal 2013, we expect to use some of this cash to further execute on our product development plan, including capital expenditures to support this plan and continued payments on our existing term loan.
Net inventories as of June 30, 2012, were $6.0 million, a decrease of $3.2 million or 35%, compared to $9.2 million as of June 30, 2011. Based upon our current forecast, we expect to increase inventories over the next year as we put in place stocking levels for product releases and increase buffer stock for projected growth in demand. Accounts payable were $3.6 million as of June 30, 2012, a decrease of $4.8 million or 57% compared to $8.4 million as of June 30, 2011. The decrease was primarily due to paying vendors on a more timely basis and reducing the balance of our net inventories. Working capital was $11.9 million as of June 30, 2012 compared to $5.2 million as of June 30, 2011. While our quarter-to-quarter results may fluctuate based on economic conditions and the timing of end-user orders, we believe that as our new products begin to take hold, we'll be able to achieve our financial targets and drive increased shareholder value. I'll now turn the call back to Kurt.